title: Octreotide neutralizes dexamethasone antitumor actions on P388 murine lymphocytic leukemia in vivo.
abstract: OBJECTIVE
  A wide variety of human malignancies, including lymphoproliferative neoplasms, express somatistatin (SS) receptors (SS-R). SS induces apoptosis and exerts pronounced antiproliferative effects on various human tumors cell lines, human xenografts, and animal tumors including P388 lymphocytic leukemia. In patients with thymoma the combination of octreotide (OCT) with corticosteroids improves the overall response rate. It has been reported that SS can increase glucocorticoid activity. Hereby, we studied the in vitro and in vivo activity of the SS analogue OCT and of the glucocorticoid dexamethasone (DEX) alone or in combination against the murine P388 lymphocytic leukemia.
  
  
  METHODS
  Cultures of P388 lymphocytic leukemia and BDF(1) male mice implanted with P388 cells where used for the in vitro an in vivo evaluation of the antileukemic activity of SS and DEX.
  
  
  RESULTS
  OCT induced a moderate and DEX a satisfactory cytostatic effect in vitro. OCT produced borderline antileukemic effect when administered on days 1-5 while DEX was effective in all schemes and routes of administration. However, none of the combination schemes exerted any anti-leukemic activity both in vitro and in vivo.
  
  
  CONCLUSIONS
  Since both SS and glucocorticoids exert direct (via receptors) and indirect antitumor actions (regulation of growth factor activity) on several cell lines, in vitro and in vivo, it becomes obvious that further in vitro studies shall provide the molecular evidence for the signal transduction pathways which are involved in the interactions of such important anticancer drugs. Based on the results of the present study, the simultaneous use of these drugs in clinical practice should be carefully considered.
authors.affiliation: 1st Department of Medical Oncology, "Metaxa" Cancer Hospital, Piraeus, Greece.
authors.forename: D T P
authors.initials: DT
authors.lastname: Trafalis
authors.forename: E
authors.initials: E
authors.lastname: Chrysogelou
authors.forename: P
authors.initials: P
authors.lastname: Dalezis
authors.forename: G
authors.initials: G
authors.lastname: Geromichalos
authors.forename: M
authors.initials: M
authors.lastname: Kontos
authors.forename: C
authors.initials: C
authors.lastname: Andreadis
authors.forename: N
authors.initials: N
authors.lastname: Ziras
authors.forename: M
authors.initials: M
authors.lastname: Koutsilieris
authors.forename: A E
authors.initials: AE
authors.lastname: Athanassiou
authors.forename: G A
authors.initials: GA
authors.lastname: Pangalis
authors.forename: A
authors.initials: A
authors.lastname: Papageorgiou